Barbara G Fox

Array ( [id] => 11032953 [patent_doc_number] => 20160229908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-11 [patent_title] => 'Antibodies Comprising an Ion Concentration Dependent Antigen-Binding Domain, Fc Region Variants, IL-8-Binding Antibodies, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/015287 [patent_app_country] => US [patent_app_date] => 2016-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 129469 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11757285 [patent_doc_number] => 20170204154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'MOLECULES THAT SELECTIVELY ACTIVATE REGULATORY T CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES' [patent_app_type] => utility [patent_app_number] => 15/002144 [patent_app_country] => US [patent_app_date] => 2016-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16580 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15002144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12927955 [patent_doc_number] => 09828430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-28 [patent_title] => Anti-IL-6/IL-6R antibodies [patent_app_type] => utility [patent_app_number] => 14/993153 [patent_app_country] => US [patent_app_date] => 2016-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 24795 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14993153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776281 [patent_doc_number] => 20160122437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'ANTIBODIES TO MATRIX METALLOPROTEINASE 9' [patent_app_type] => utility [patent_app_number] => 14/992678 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10159 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075742 [patent_doc_number] => 20160272706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'IL-13 BINDING PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/992281 [patent_app_country] => US [patent_app_date] => 2016-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 35131 [patent_no_of_claims] => 81 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17742630 [patent_doc_number] => 11390687 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Bispecific antibodies against plasma kallikrein and Factor XII [patent_app_type] => utility [patent_app_number] => 15/541066 [patent_app_country] => US [patent_app_date] => 2015-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 24 [patent_no_of_words] => 22220 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 635 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10988906 [patent_doc_number] => 20160185851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'ANTIBODIES TO INTERLEUKIN-6 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/985642 [patent_app_country] => US [patent_app_date] => 2015-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 16808 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14985642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11814950 [patent_doc_number] => 09718892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Method of treating myocardial infarction by administering a bi-specific fusion protein' [patent_app_type] => utility [patent_app_number] => 14/967980 [patent_app_country] => US [patent_app_date] => 2015-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 75 [patent_no_of_words] => 37576 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10744257 [patent_doc_number] => 20160090407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'INTERLEUKIN-2 FUSION PROTEINS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/967019 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 27198 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14967019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10750735 [patent_doc_number] => 20160096886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'METHODS FOR ADMINISTERING ANTI-IL-5 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/965130 [patent_app_country] => US [patent_app_date] => 2015-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8484 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14965130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10743282 [patent_doc_number] => 20160089433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-31 [patent_title] => 'Induction of IL-12 using immunotherapy' [patent_app_type] => utility [patent_app_number] => 14/962728 [patent_app_country] => US [patent_app_date] => 2015-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5792 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11956134 [patent_doc_number] => 20170260285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/529315 [patent_app_country] => US [patent_app_date] => 2015-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19284 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15529315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13447161 [patent_doc_number] => 20180275123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-27 [patent_title] => PEPTIDES FOR BLOCKING IL1RAP PROTEIN-PROTEIN INTERACTION AND USES THEREOF FOR TREATMENT OF DISEASE [patent_app_type] => utility [patent_app_number] => 15/524363 [patent_app_country] => US [patent_app_date] => 2015-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5297 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15524363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14016541 [patent_doc_number] => 20190070264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => INTERLEUKIN 15 PROTEIN COMPLEX AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 15/537107 [patent_app_country] => US [patent_app_date] => 2015-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13383693 [patent_doc_number] => 20180243388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING MELANOMA [patent_app_type] => utility [patent_app_number] => 15/526256 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10714177 [patent_doc_number] => 20160060323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'ZCYTOR17 HETERODIMERIC CYTOKINE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 14/937919 [patent_app_country] => US [patent_app_date] => 2015-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 85947 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10813757 [patent_doc_number] => 20160159917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'TRIMERIC ANTIGEN BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/934639 [patent_app_country] => US [patent_app_date] => 2015-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25344 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14934639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10706868 [patent_doc_number] => 20160053015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'ANTIBODIES AGAINST HUMAN CSF-1R AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/927373 [patent_app_country] => US [patent_app_date] => 2015-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17434 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14927373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17434770 [patent_doc_number] => 11260076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Methods and compositions for natural killer cells [patent_app_type] => utility [patent_app_number] => 15/522361 [patent_app_country] => US [patent_app_date] => 2015-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 14439 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13209221 [patent_doc_number] => 10118967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-06 [patent_title] => Methods for treating rheumatoid arthritis by administering IL-6 receptor antibodies [patent_app_type] => utility [patent_app_number] => 14/904864 [patent_app_country] => US [patent_app_date] => 2015-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 31937 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904864 [rel_patent_id] =>[rel_patent_doc_number] =>)